Sheets Smith Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Hold
486
0.03% 367
2026
Q1
$273K Buy
486
+25
+5% +$16K 0.03% 357
2025
Q4
$312K Buy
461
+6
+1% +$4.09K 0.03% 343
2025
Q3
$291K Hold
455
0.03% 352
2025
Q2
$244K Sell
455
-125
-22% -$59.8K 0.03% 369
2025
Q1
$244K Buy
+580
New +$252K 0.03% 324
2024
Q4
Sell
-450
Closed -$227K 383
2024
Q3
$227K Hold
450
0.03% 349
2024
Q2
$219K Hold
450
0.03% 353
2024
Q1
$243K Buy
+450
New +$246K 0.03% 348
2020
Q1
Sell
-2,513
Closed -$651K 300
2019
Q4
$651K Sell
2,513
-41
-2% -$10.8K 0.12% 168
2019
Q3
$695K Buy
2,554
+305
+14% +$84.9K 0.14% 157
2019
Q2
$619K Buy
+2,249
New +$554K 0.13% 172

Other funds holding IDXX

Sheets Smith Wealth Management's IDXX Position: Q2 2026 in Review

Sheets Smith Wealth Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 486 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #367.

Sheets Smith Wealth Management first reported a position in IDXX in Q2 2019 and has held it in 12 quarters since. The position peaked at $695K in Q3 2019. 172 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sheets Smith Wealth Management held 486 shares of Idexx Laboratories worth $256K as of Q2 2026.
  • Sheets Smith Wealth Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.03% of Sheets Smith Wealth Management's portfolio in Q2 2026, its #367 holding.
  • Sheets Smith Wealth Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 12 quarters since.
  • Sheets Smith Wealth Management's Idexx Laboratories position peaked at $695K in Q3 2019.
  • 172 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.